LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Lidocaine Hydrochloride 0.2% In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Lidocaine Hydrochloride 0.2% In Dextrose 5% In Plastic Container launch?
Lidocaine Hydrochloride 0.2% In Dextrose 5% In Plastic Container is a drug marketed by Abbott and Hospira and is included in two NDAs.
The generic ingredient in LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride 0.2% In Dextrose 5% In Plastic Container
A generic version of LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 1,820 |
| DailyMed Link: | LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sichuan Cancer Hospital and Research Institute | N/A |
| Jessyka Lighthall | Phase 3 |
| Sawanpracharak hospital | N/A |
See all LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER | lidocaine hydrochloride | INJECTABLE;INJECTION | 018954-001 | Jul 9, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hospira | LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER | lidocaine hydrochloride | INJECTABLE;INJECTION | 018388-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
